Biological properties of vitamin B 12 .
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing known biological and clinical mechanisms without systematic trial review.
PubMed 39376196 · doi:10.1017/S0954422424000210
What was done
This narrative review synthesizes the biological and clinical aspects of vitamin B12 (cobalamin). It outlines its biochemical functions as a cofactor in two human enzymatic reactions (the conversion of L-methylmalonyl-CoA to succinyl-CoA and the methylation of homocysteine to methionine), its natural dietary sources, food stability, pharmacokinetics, absorption and storage mechanisms, causes and clinical symptoms of deficiency, analytical diagnostic methods, and strategies for prevention, pharmacological treatment, and potential toxicity.
What was found
The abstract provides a qualitative summary and reports no numerical data or effect estimates. It highlights that eukaryotes cannot synthesize vitamin B12, requiring humans to obtain it from dietary animal sources (meat, milk, dairy, fish, shellfish, eggs). Consequently, vegetarians are at risk of developing deficiency and need fortified foods. It also notes that vitamin B12 is distinct from most other B-complex vitamins due to greater stability, a highly specific absorption mechanism, and large-capacity body storage.
Why it matters
It provides a consolidated reference on the physiological mechanisms, dietary requirements, and diagnostic and therapeutic management of vitamin B12 deficiency.
Limits
The abstract contains no empirical human study data, statistical metrics, or quantitative synthesis. As a narrative review, it lacks a documented systematic search strategy, defined inclusion criteria, and formal risk-of-bias assessment. Specific diagnostic assay accuracy values and deficiency prevalence rates are not reported in the abstract.
Cited by
- contradicts Cyanocobalamin does not break down or become active in individuals with methylation issues, resulting in toxic buildup in the body.